Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Body Composition and Adipose Tissue in HIV Lipodystrophy: Effects of Tesamorelin Therapy

NCT03226821 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03226821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Body Composition and Adipose Tissue in HIV Lipodystrophy: Effects of Tesamorelin Therapy
Lead sponsor
Columbia University
Phase
Phase 4
Overall status
Terminated
Start date
February 7, 2018
Completion date
April 30, 2025
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body composition, growth hormone deficiency, hiv lipodystrophy syndrome